title: Cholesterol biosynthesis from birth to adulthood in a mouse model for 7-dehydrosterol reductase deficiency (Smith-Lemli-Opitz syndrome).
abstract: Smith-Lemli-Opitz syndrome (SLOS) is caused by deficiency in the terminal step of cholesterol biosynthesis, which is catalyzed by 7-dehydrocholesterol reductase (DHCR7). The disorder exhibits several phenotypic traits including dysmorphia and mental retardation with a broad range of severity. Pathogenesis of SLOS is complex due to multiple roles of cholesterol and may be further complicated by unknown effects of aberrant metabolites that arise when 7-dehydrocholesterol (7-DHC), the substrate for DHCR7, accumulates. A viable mouse model for SLOS has recently been developed, and here we characterize cholesterol metabolism in this model with emphasis on changes during the first few weeks of postnatal development. Cholesterol and 7-DHC were measured in "SLOS" mice and compared with measurements in normal mice. SLOS mice had measurable levels of 7-DHC at all ages tested (up to 1 year), while 7-DHC was below the threshold for detection in normal mice. In perinatal to weaning age SLOS mice, cholesterol and 7-DHC levels changed dramatically. Changes in brain and liver were independent; in brain cholesterol increased several fold while 7-DHC remained relatively constant, but in liver cholesterol first increased then decreased again while 7-DHC first decreased then increased. In older SLOS animals the ratio of 7-DHC/cholesterol, which is an index of biochemical severity, tended to approach, but not reach, normal. While these mice provide the best available genetic animal model for the study of SLOS pathogenesis and treatment, they probably will be most useful at early ages when the metabolic effects of the mutations are most dramatic. To correlate any experimental treatment with improved sterol metabolism will require age-matched controls. Finally, determining the mechanism by which these "SLOS" mice tend to normalize may provide insight into the future development of therapy.
authors: Children's Hospital Oakland Research Institute, Oakland, CA 94609-1673, USA.
authors: Josep
authors: J
authors: Marcos
authors: Cedric H L
authors: CH
authors: Shackleton
authors: Madhavee M
authors: MM
authors: Buddhikot
authors: Forbes D
authors: FD
authors: Porter
authors: Gordon L
authors: GL
authors: Watson
mesh_terms: D000375:Aging / Q000378:metabolism*; D000818:Animals; D000831:Animals, Newborn / Q000378:metabolism*; D001921:Brain / Q000201:enzymology; D002784:Cholesterol / Q000096:biosynthesis*; D004195:Disease Models, Animal; D008099:Liver / Q000201:enzymology; D051379:Mice; D044925:Oxidoreductases Acting on CH-CH Group Donors / Q000172:deficiency*; D019082:Smith-Lemli-Opitz Syndrome / Q000201:enzymology / Q000378:metabolism*; D014020:Tissue Extracts
chemical_list: D014020:Tissue Extracts; D002784:Cholesterol; D044925:Oxidoreductases Acting on CH-CH Group Donors; C019995:7-dehydrocholesterol reductase
references: Am J Med Genet. 2001 Jan 15;98(2):191-200
references: 11223857
references: J Lipid Res. 1998 Aug;39(8):1594-600
references: 9717719
references: Prenat Diagn. 2001 Mar;21(3):207-12
references: 11260610
references: Curr Opin Lipidol. 2001 Apr;12(2):105-12
references: 11264981
references: Am J Med Genet. 2001 Jul 22;102(1):18-20
references: 11471166
references: Am J Med Genet. 2001 Sep 1;102(4):383-6
references: 11503168
references: J Clin Invest. 2001 Sep;108(6):905-15
references: 11560960
references: Annu Rev Genomics Hum Genet. 2001;2:299-341
references: 11701653
references: Curr Opin Pediatr. 2003 Dec;15(6):607-13
references: 14631207
references: J Pharm Biomed Anal. 1998 Jun;17(2):193-218
references: 9638572
references: Am J Med Genet. 1997 Jan 31;68(3):311-4
references: 9024565
references: Am J Med Genet. 1999 Feb 19;82(5):376-81
references: 10069707
references: Curr Opin Pediatr. 1999 Aug;11(4):353-62
references: 10439210
references: Mol Genet Metab. 2005 Feb;84(2):112-26
references: 15670717
references: Mol Genet Metab. 2005 Jun;85(2):96-107
references: 15896653
references: Cell. 2006 Jan 13;124(1):35-46
references: 16413480
references: Hum Mol Genet. 2006 Mar 15;15(6):839-51
references: 16446309
references: Prenat Diagn. 2006 Sep;26(9):842-9
references: 16832833
references: Am J Med Genet A. 2006 Oct 1;140(19):2057-62
references: 16906538
references: Eur J Med Genet. 2006 Nov-Dec;49(6):499-504
references: 16497572
references: J Med Genet. 1998 Jul;35(7):558-65
references: 9678700
references: Am J Med Genet. 2000 Jan 31;90(3):260
references: 10678669
references: J Med Genet. 2000 May;37(5):321-35
references: 10807690
references: J Lipid Res. 2000 Aug;41(8):1339-46
references: 10946022
references: Mol Genet Metab. 2001 Jan;72(1):67-71
references: 11161831
references: J Pediatr. 2004 Jun;144(6):783-91
references: 15192627
references: J Lipid Res. 2004 Aug;45(8):1375-97
references: 15254070
references: Am J Med Genet. 1980;5(2):137-43
references: 7395908
references: Am J Med Genet. 1995 Apr 10;56(3):281-5
references: 7778590
references: Clin Chim Acta. 1995 Apr 30;236(1):45-58
references: 7664465
references: Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8460-4
references: 8710893
references: Am J Med Genet. 1997 Jan 31;68(3):305-10
references: 9024564
references: Hum Mol Genet. 2001 Mar 15;10(6):555-64
references: 11230174